Assembly Biosciences, Inc. (ASMB)
23.53
+0.71
(+3.11%)
USD |
NASDAQ |
Oct 09, 16:00
23.50
-0.03
(-0.13%)
After-Hours: 20:00
Assembly Biosciences Price : 23.53 for Oct. 9, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 09, 2026 | 23.00 | 23.58 | 22.72 | 23.53 | 170489.0 |
| Oct 08, 2026 | 22.78 | 23.05 | 22.08 | 22.82 | 288405.0 |
| Oct 07, 2026 | 21.95 | 23.13 | 21.80 | 22.95 | 190787.0 |
| Oct 06, 2026 | 22.84 | 22.92 | 21.80 | 22.18 | 349445.0 |
| Oct 05, 2026 | 22.68 | 22.95 | 22.27 | 22.74 | 241747.0 |
| Oct 02, 2026 | 23.30 | 23.48 | 22.01 | 22.54 | 368313.0 |
| Oct 01, 2026 | 23.18 | 23.66 | 22.75 | 22.98 | 350803.0 |
| Sep 30, 2026 | 23.65 | 23.86 | 23.22 | 23.49 | 221147.0 |
| Sep 29, 2026 | 23.70 | 23.79 | 23.05 | 23.48 | 229740.0 |
| Sep 28, 2026 | 23.35 | 23.86 | 23.05 | 23.61 | 117454.0 |
| Sep 25, 2026 | 23.70 | 24.25 | 23.43 | 23.67 | 143523.0 |
| Sep 24, 2026 | 23.73 | 24.02 | 23.15 | 23.66 | 179020.0 |
| Sep 23, 2026 | 25.42 | 25.63 | 23.89 | 23.97 | 275247.0 |
| Sep 22, 2026 | 25.69 | 25.89 | 25.12 | 25.45 | 1.070M |
| Sep 21, 2026 | 25.40 | 25.73 | 24.85 | 25.44 | 211868.0 |
| Sep 18, 2026 | 25.41 | 25.78 | 24.83 | 24.97 | 1.414M |
| Sep 17, 2026 | 26.02 | 26.30 | 25.10 | 25.34 | 364771.0 |
| Sep 16, 2026 | 26.11 | 26.69 | 25.13 | 25.48 | 348789.0 |
| Sep 15, 2026 | 29.00 | 29.66 | 25.31 | 26.11 | 588853.0 |
| Sep 14, 2026 | 30.31 | 30.48 | 28.79 | 28.96 | 290474.0 |
| Sep 11, 2026 | 30.83 | 31.72 | 29.68 | 29.80 | 258946.0 |
| Sep 10, 2026 | 32.56 | 32.69 | 30.34 | 30.46 | 348622.0 |
| Sep 09, 2026 | 35.64 | 35.92 | 32.73 | 32.87 | 724817.0 |
| Sep 08, 2026 | 36.16 | 36.68 | 35.14 | 35.28 | 227771.0 |
| Sep 04, 2026 | 35.68 | 36.76 | 35.48 | 36.60 | 156452.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Gilead Sciences, Inc. | 151.17 |
| BridgeBio Pharma, Inc. | 65.35 |
| ACADIA Pharmaceuticals, Inc. | 19.78 |
| Alnylam Pharmaceuticals, Inc. | 232.68 |
| Anika Therapeutics, Inc. | 19.58 |
Price Related Metrics
| PS Ratio | 5.053 |
| Price to Book Value | 1.528 |
| Earnings Yield | -0.31% |
| Market Cap | 467.08M |